Dr. Sandra Lynn Gregory, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 3330 Preston Ridge Rd Ste 100, Alpharetta, GA 30005 Phone: 770-255-7500 Fax: 770-255-7501 |
Dr. Rajashakher P Reddy, M.D. Radiology - Body Imaging Medicare: Not Enrolled in Medicare Practice Location: 560 Blue Heron Way, Alpharetta, GA 30004 Phone: 404-692-3493 |
Dr. Stephanie Sue Heinlen, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 102 Grand Crescent, Alpharetta, GA 30009 Phone: 952-595-1100 Fax: 612-294-4903 |
Dr. Mark William Mccord, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 3330 Preston Ridge Rd Ste 100, Alpharetta, GA 30005 Phone: 770-350-0126 Fax: 770-350-6637 |
Dr. Samuel Edward Brown, M.D. Radiology - Neuroradiology Medicare: Not Enrolled in Medicare Practice Location: 540 Owens Farm Rd, Alpharetta, GA 30004 Phone: 404-966-6464 Fax: 678-624-9976 |
Dr. Ranie William Pendarvis, M.D. Radiology - Diagnostic Radiology Medicare: May Accept Medicare Assignments Practice Location: 3107 Watsons Bnd, Alpharetta, GA 30004 Phone: 678-691-0487 Fax: 678-691-0487 |
News Archive
Now, a new Israeli study published on the preprint server bioRxiv in June 2020 reports a new recombinant vaccine expressing the S or spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be highly protective with a single dose in an animal model. This could be a gamechanger in the fight to contain the outbreak.
Long-term use of commonly prescribed heartburn and ulcer medications is linked to a higher risk of vitamin B12 deficiency, according to a new study published online in the Journal of the American Medical Association.
As vaccine efforts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease, roll out in various countries, Moderna ups the game by testing its next-generation COVID-19 vaccine.
Dartmouth scientists have created a more sustainable feed for aquaculture by using a marine microalga co-product as a feed ingredient.
A California Institute of Technology -led team of researchers and clinicians has published the first proof that a targeted nanoparticle-used as an experimental therapeutic and injected directly into a patient's bloodstream-can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi).
› Verified 1 days ago